echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > J Diabetes Res: Study on the key active ingredients and pharmacological mechanism of Tangshen Recipe in the treatment of diabetic nephropathy

    J Diabetes Res: Study on the key active ingredients and pharmacological mechanism of Tangshen Recipe in the treatment of diabetic nephropathy

    • Last Update: 2021-09-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Diabetic nephropathy (DN) is a common and serious micro diabetes (DM) vascular complication, is the main cause of end-stage renal disease (ESRD) is an important factor for diabetes morbidity and mortality
    .


    According to epidemiological evidence, about 15-40% of diabetic patients can worsen to DN


    Diabetic vascular major cause of end stage renal disease (with ESRD) is a major cause of end stage renal disease (with ESRD) of

    Current studies believe that the occurrence and development of DN is mainly related to metabolic disorders (abnormal lipid metabolism, glucose metabolism disorders, etc.
    ), protein kinase C activation, oxidative stress, inflammation, hemodynamic changes, and genetic factors
    .


    Existing drug therapy is mainly to control hyperglycemia and hypertension, such as angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists (ACEI/ARB)


    These drugs cannot prevent DN from continuing to develop.


    Chinese herbal medicine Multi-component, multi-target, multi-pathway and synergistic effect of Chinese herbal medicine Multi-component, multi -target, multi-pathway and synergistic effect

    A recent study published in the Journal of Diabetes Research, used network pharmacology to study the key active components of TSF in the treatment of DN and their pharmacological mechanism , and explore the biologically active components of TSF on DN and the overall potential mechanism
    .

    Key active ingredients and their pharmacological mechanism of actionKey active ingredients and their pharmacological mechanism of action

    The results show that TSF treatment of DN has the characteristics of multiple components, multiple targets, multiple pathways and synergy
    .


    Quercetin, naringenin, kaempferol, and isorhamnetin are the key active compounds, PI3K-Akt signaling pathway, TNF signaling pathway, non-alcoholic fatty liver (NAFLD) signaling pathway, local adhesion, rap1 signaling pathway, T cell Receptor signaling pathway, MAPK signaling pathway, and insulin resistance are the key molecular mechanisms of TSF treatment of DN, and they play an important role in TSF treatment of DN


    Quercetin, naringenin, mountain phenol, isorhamnetin quercetin, naringenin, mountain phenol, Isorhmnetin non-alcoholic fatty liver key molecular mechanisms of key molecular mechanism

    references:

    references:

    [1]Weie Zhou, Xuefeng Zhou, Yuan Zhang,et al.


    [1]Weie Zhou, Xuefeng Zhou, Yuan Zhang,et al.
    A Network Pharmacology-Based Approach for Exploring Key Active Compounds and Pharmacological Mechanisms of Tangshen Formula for Treatment of Diabetic Nephropathy.
    Journal of Diabetes Research.
    vol.
    2021, Article ID 8833688 , 17 pages, 2021.
    https://doi.
    org/10.
    1155/2021/8833688 Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.